Immunotherapy Clinical Trials - A New Approach to Treating Cancer
Go back to Immunotherapy Clinical Trials - A New Approach to Treating Cancer| Aethlon Medical, Inc. (NASDAQ: AEMD) | Delayed: 2.10 -0.11 (4.98%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.21 | 52 Week High | $9.09 | |||
| Open | $2.10 | 52 Week Low | $4.02 | |||
| Day High | $2.15 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $-0.05 | |||
| Volume | 270,890 | |||||
